TGViewer
Bloomberg Bloomberg @bloomberg · 176K subscribers
Post #3092 30.7K
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk and Eli Lilly. Read more here: https://bloom.bg/4llYYLR
Bloomberg.com Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co.
  • 🤔 22
  • ❤ 15
  • 👏 14
  • 👍 4
  • 😱 4
  • 😁 1
Open in Telegram All posts from @bloomberg
More from @bloomberg
  1. Sep 3, 2026EXCLUSIVE: TikTok developer ByteDance secures a $30 billion loan in Asia’s second-largest…
  2. Sep 2, 2026The Nepal disaster is the latest example of how climate change is raising the risk of rely…
  3. Sep 2, 2026Jaguar Land Rover's first electric Range Rover will start at $208,420, a price tag that wi…
  4. Sep 2, 2026Japan has a $640 billion investment plan to become an AI and chip powerhouse. Kioxia’s boo…
  5. Sep 2, 2026Apple says that new CEO John Ternus will get a compensation package worth about $58 millio…
  6. Aug 27, 2026🚨 LIVE NOW: Tata Chairman N. Chandrasekaran's shock decision to not continue beyond Febru…
Threads Profile ViewerView any public Threads profile without an account.Open ThreadLook →Writing with AI? Make it sound human.Metric37 rewrites AI drafts so they read naturally. Free AI detector, 1,500 words free.Try Metric37 →